Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk
Ye Lu(Hangzhou Academy of Agricultural Sciences), Angelo Andriulli(Casa Sollievo della Sofferenza), Pavel Vodička(Charles University), Audrius Ivanauskas(Lithuanian University of Health Sciences), Dezső Kelemen(University of Pecs), Sabrina Gloria Giulia Testoni(Istituti di Ricovero e Cura a Carattere Scientifico), Lívia Archibugi(Vita-Salute San Raffaele University), Maria Chiara Petrone(Vita-Salute San Raffaele University), J Novák(Békés Megyei Központi Kórház), Zdeněk Kala(Masaryk University), Luca Morelli(University of Pisa), Manuel Gentiluomo(University of Pisa), Maria Gazouli(National and Kapodistrian University of Athens), Martin Oliverius(Charles University), Markus K. Diener(Paracelsus Medical University), William Greenhalf(University of Liverpool), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Giulia Martina Cavestro(University of Parma), Konstantinos Papiris(Hippocration General Hospital), Daniela Basso(University of Padua), Angelica Macauda(German Cancer Research Center), Krzysztof Jamroziak(Instytut Hematologii i Transfuzjologi), Jakob R. Izbicki(Universität Hamburg), Domenica Gioffreda(Casa Sollievo della Sofferenza), George Theodoropoulos(National and Kapodistrian University of Athens), Martin Loveček(University Hospital Olomouc), Andrea Szentesi(University of Pecs), Raffaele Pezzilli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), John P. Neoptolemos(University of Liverpool), Mateus Nóbrega Aoki(Fundação Carlos Chagas), Laura Ginocchi(Azienda Usl Toscana Centro), Viktor Hlaváč(Charles University), Juozas Kupčinskas(Lithuanian University of Health Sciences), Giuseppe Vanella(Azienda Ospedaliera Sant'Andrea), Roberto Salvia(University of Verona), Stefano Ermini(Meyer Children's Hospital), Faik G. Uzunoǧlu(Universität Hamburg), Hermann Brenner(Universidad de Granada), Andrea Mambrini, Ondřej Strouhal(University Hospital Olomouc), Roger Chammas(Universidade de São Paulo), Cosimo Sperti(University of Padua), Vytautas Kiudelis(Lithuanian University of Health Sciences), Balázs Csaba Németh(University of Szeged), Bas Bueno‐de‐Mesquita(University Medical Center Utrecht), Anna Caterina Milanetto(University of Padua), Pavel Souček(National Institute of Public Health), Thilo Hackert(Universität Hamburg), Beatrice Mohelníková-Duchoňová(University Hospital Olomouc), Stefania Moz(University of Padua)
Cited by 12
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k